News|Articles|March 15, 2020
Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon
Author(s)J. Mark Wiggins, Joseph A. Albanese
This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
3
Balancing Unpredictable Tariffs with Geographically Segregated Supply Chains
4
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
5